Sep 30, 2021
Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption
Covance Laboratories has created a portfolio of differentiated hospital products primarily for use by anesthesiologists and a promising late-stage development candidate targeting oncologists.
Covance Laboratories plans to commercialize its current pipeline products directly in the UK via its own commercial organization targeting anaesthesiologists and oncologists.
Partnering
Covance Laboratories is a commercial stage biopharmaceutical group focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy.
Investors